Jeff Yass’s Apexigen, Inc. WarrantApexigen, Inc. Warrant APGNW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-31,626
Closed -$791 13398
2023
Q2
$791 Buy
31,626
+6,333
+25% +$277 ﹤0.01% 11911
2023
Q1
$1.52K Sell
25,293
-122,644
-83% -$10.4K ﹤0.01% 12393
2022
Q4
$3.71K Sell
147,937
-15,498
-9% -$1.24K ﹤0.01% 12084
2022
Q3
$36K Buy
+163,435
New +$40.3K ﹤0.01% 12388

Other funds holding APGNW

Jeff Yass's APGNW Position: Q3 2023 in Review

Jeff Yass sold out of Apexigen, Inc. WarrantApexigen, Inc. Warrant (APGNW) in Q3 2023, closing a stake of 31,626 shares — an estimated $791 sold.

Jeff Yass first reported a position in APGNW in Q3 2022 and held it in 4 quarters. The position peaked at $36K in Q3 2022. 1 fund tracked by Wall St. Rank holds APGNW as of Q3 2023.

  • Jeff Yass reported no remaining Apexigen, Inc. WarrantApexigen, Inc. Warrant position as of Q3 2023 after selling out during the quarter.
  • Jeff Yass sold 31,626 Apexigen, Inc. WarrantApexigen, Inc. Warrant shares in Q3 2023, an estimated $791.
  • Jeff Yass first reported a position in Apexigen, Inc. WarrantApexigen, Inc. Warrant in Q3 2022 and held it in 4 quarters.
  • Jeff Yass's Apexigen, Inc. WarrantApexigen, Inc. Warrant position peaked at $36K in Q3 2022.
  • 1 fund tracked by Wall St. Rank held Apexigen, Inc. WarrantApexigen, Inc. Warrant as of Q3 2023.

Based on Susquehanna International Group's 13F filing for Q3 2023, filed 14 Nov 2023.